Skip to content

CorMedix CRMD Preferred Stock

Preferred Stock at other companies

Merit Medical Systems logo
Merit Medical SystemsMMSI
$0
IAR
Integra LifeSciencesIART
$0
Emergent Biosolutions logo
Emergent BiosolutionsEBS
$0
ICU Medical logo
ICU MedicalICUI
$0
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$0
Medline, Inc.
 logo
Medline, Inc. MDLN
$0

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockValue.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's preferred stock.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's preferred stock?
CorMedix (CRMD) reported preferred stock of $0 in Q1 2026.
How has CorMedix's preferred stock changed year-over-year?
CorMedix's preferred stock decreased by 100.0% year-over-year, from $92 to $0.
What is the long-term trend for CorMedix's preferred stock?
Over 5 years (2020 to 2025), CorMedix's preferred stock has grown at a -100.0% compound annual growth rate (CAGR), from $242 to $0.
What does preferred stock mean?
Equity securities with priority over common stock for dividends and liquidation proceeds, but typically without voting rights.